福元医药 (601089)
Beijing Foyou Pharma Co., Ltd.
K-Line Chart
No K-line data available
Company NameBeijing Fuyuan Pharmaceutical Co., Ltd.
Listing Date2022-06-30
Issue Price14.62RMB
Registered Capital4800010k RMB
Legal RepresentativeHe Huang
Registered AddressNo. 8 Guangyuan East Street, Tongzhou Industrial Development Zone, Tongzhou District, Beijing
IndustryChemical Pharmaceuticals
Main BusinessResearch and development, production, and sales of pharmaceutical preparations and medical devices.
Company ProfileBeijing Fuyuan Pharmaceutical Co., Ltd. is primarily engaged in the research and development, production, and sales of pharmaceutical preparations and medical devices. Its products possess strong competitiveness and high market recognition. The company has been selected as a G20 enterprise under Beijing's Pharmaceutical Industry Leapfrog Development Project, ranked among China's Top 100 Pharmaceutical R&D Powerhouses and Beijing's Top 100 Private Enterprises in Technological Innovation, receiving widespread recognition within and outside the industry.
The company adheres to the philosophy of innovation-driven development. As a national innovative generic drug industrialization base, it has established a research and development strategy focusing on clinical needs and combining imitation with innovation. In the field of pharmaceutical preparations, the company has 7 domestically first-to-market generic products and 19 varieties that have passed or are deemed to have passed the consistency evaluation. It has also begun exploring new areas such as innovative chemical drugs. In the medical device field, the company focuses on micro-innovation in clinical care products, supplemented by home healthcare products, and possesses independent intellectual property rights. The company has a relatively sufficient technology reserve, owning 254 authorized patents, including 78 invention patents. It has a rich pipeline of products under development, including 24 generic drug preparation projects, 3 innovative drug projects, and 4 medical device projects.
Stock Details
1. Key Indicators
- Total Shares(W): 48000.00
- Circulating A-Shares(W): 48000.00
- Earnings Per Share(RMB): 0.7800
- Net Assets Per Share(RMB): 7.6778
- Operating Revenue(W RMB): 252060.51
- Total Profit(W RMB): 41786.34
- **Net Profit Attributable to Parent(W RMB) **: 37534.04
- Net Profit Growth Rate(%): -6.39
- Weighted Return on Equity(%): 10.3500
- Operating Cash Flow Per Share(RMB): 0.6550
- Undistributed Profit Per Share(RMB): 3.1597
- Capital Reserve Per Share(RMB): 3.4633
2. Main Business
The main business covers:
- Research, development, production and sales of pharmaceutical preparations and medical devices
3. Company Basic Information
- Company Name: Beijing Foyou Pharmaceutical Co., Ltd.
- Listing Date: 2022-06-30
- Industry: Pharmaceutical Manufacturing
- Address: No. 8 Guangyuan East Street, Tongzhou Industrial Development Zone, Beijing
- Website: https://www.foyou.com.cn/
- Company Profile: The company was formerly known as Wansheng Pharmaceutical and was restructured into Beijing Foyou Pharmaceutical Co., Ltd. in 2019. It is mainly engaged in the research, development, production and sales of pharmaceutical preparations and medical devices.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | XINCHENG HOLDING GROUP CO., LTD. | Corporate Legal Person | 17631.64 | 36.73 |
| 2 | XINCHANG QINJIN INVESTMENT CO., LTD. | Corporate Legal Person | 9833.72 | 20.49 |
| 3 | BEIJING HUAKANG TAIFENG TECHNOLOGY CO., LTD. | Corporate Legal Person | 7024.09 | 14.63 |
| 4 | HONG KONG SECURITIES CLEARING COMPANY LTD. | Northbound Capital | 425.24 | 0.89 |
| 5 | CHINA FOREIGN ECONOMIC AND TRADE TRUST CO., LTD. - FOREIGN TRADE TRUST - CHONGYANG TARGET RETURN 1 SECURITIES INVESTMENT COLLECTIVE FUND TRUST PLAN | Asset Management Plan | 382.64 | 0.80 |
| 6 | XUANCHENG RENHE INVESTMENT PARTNERSHIP (LIMITED PARTNERSHIP) | Corporate Legal Person | 378.25 | 0.79 |
| 7 | YIFANGDA HEALTHCARE INDUSTRY MIXED SECURITIES INVESTMENT FUND CLASS A | Fund | 256.38 | 0.53 |
| 8 | PINGAN XINXIN PIONEER MIXED SECURITIES INVESTMENT FUND CLASS A | Fund | 212.37 | 0.44 |
5. Concept Sectors
- Assisted Reproduction
- Innovative Drugs
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information